US Stem Cell

US Stem Cell PP&E per Employee

The PP&E per Employee of US Stem Cell (USRM) as of Oct 29, 2026 is 80,871.67 USD. In the previous year, PP&E per Employee was 149,915.67 USD — a change of -46.06% (lower).

PP&E per Employee

80,871.67USD

YoY

-46.06%

Last updated:

PP&E per Employee of US Stem Cell is 2018 80,871.67 USD. PP&E per Employee of US Stem Cell was 2017 149,915.67 USD. It decreases by -46.06% lower compared to the previous year.

The US Stem Cell PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2014
4,228.67 USD
Jan 1, 2015
4,724.00 USD
Jan 1, 2016
6,989.67 USD
Jan 1, 2017
149,915.67 USD
Jan 1, 2018
80,871.67 USD
The US Stem Cell PP&E per Employee history
YEARPP&E per EmployeeYoY
80,871.67USD-46.06%
149,915.67USD+2,044.82%
6,989.67USD+47.96%
4,724.00USD+11.71%
4,228.67USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

US Stem Cell Stock analysis

What does US Stem Cell do? US Stem Cell Inc is a company specializing in the field of regenerative medicine. It was founded in 1999 and is headquartered in Sunrise, Florida. The company has experienced rapid development in recent years and is one of the leading providers of stem cell therapies in the USA. The business model of US Stem Cell is based on the development and marketing of stem cell products and therapies that are intended to help patients improve their health and treat diseases. The company focuses on a range of therapeutic applications, such as the treatment of degenerative diseases, injuries, and chronic pain. US Stem Cell operates several divisions, including the Cell Processing and Storage Center, which specializes in the processing and storage of stem cells. The company also has its own research and development team that develops products and therapies and subjects them to clinical trials. US Stem Cell offers various products and therapies, including autologous stem cell therapy. In this treatment, stem cells are taken from the patient's own body, processed, and then used at the affected site. This is intended to aid in the regeneration of damaged tissue and reduce inflammation in the body. Another treatment method is the use of exogenous stem cells sourced from other donors. US Stem Cell has also entered into a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to research and develop technology for the production of biological materials and tissues. This collaboration aims to increase the availability of stem cell therapies and advance research in this field. US Stem Cell has experienced some controversies in recent years, particularly related to the use of inappropriate protocols and the performance of stem cell therapies without sufficient scientific evidence. However, the company has emphasized that their therapies are based on scientific knowledge and rigorous protocols, and that they work closely with medical professionals to ensure the safety and efficacy of their treatments. Overall, US Stem Cell Inc has established itself as a significant player in the field of regenerative medicine, particularly in the area of stem cell therapy. The company is committed to developing new therapies that help patients improve their quality of life and treat diseases. Despite some controversies, US Stem Cell remains an important and promising company in the biotechnology industry. US Stem Cell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about US Stem Cell stock

PP&E per Employee of US Stem Cell is 80,871.67 USD in 2018.

PP&E per Employee of US Stem Cell changed from 149,915.67 USD to 80,871.67 USD, representing a -46.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee US Stem Cell since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's US Stem Cell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — US Stem Cell

All Key Metrics — US Stem Cell